Bionpharma Inc. 2024-10-23 Health critical FDA
Health · FDA · Recall #FDA-D-0012-2025
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by:… Recall
Issued October 23, 2024 · Bionpharma Inc.
In October 2024, Bionpharma Inc. recalled the Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by:…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
What you should do
- 1 Stop using Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Bionpharma Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Bionpharma Inc.
- Category
- Health
- Recall date
- October 23, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the U.S.A.
- Recall number
- FDA-D-0012-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Bionpharma Inc. has 1 recall in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.